Synthesis and antiproliferative screening of novel doubly modified colchicines containing urea, thiourea and guanidine moieties

Bioorg Med Chem Lett. 2021 Sep 1:47:128197. doi: 10.1016/j.bmcl.2021.128197. Epub 2021 Jun 8.

Abstract

A new series of 10-demethoxy-10-methylaminocolchicines bearing urea, thiourea or aguanidine moieties at position C7 has been designed, synthesized and evaluated for in vitro anticancer activity against different cancer cell lines (A549, MCF-7, LoVo, LoVo/DX). The majority of the new derivatives were active in the nanomolar range and were characterized by lower IC50 values than cisplatin or doxorubicin. Two ureas (4 and 8) and thioureas (19 and 25) were found to be good antiproliferative agents (low IC50 values and high SI) and could prove to be promising candidates for further research in the field of anticancer drugs based on the colchicine skeleton.

Keywords: Anticancer agents; Antiproliferative activity; Colchicine derivatives.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Colchicine / chemical synthesis
  • Colchicine / chemistry
  • Colchicine / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Guanidine / chemistry
  • Guanidine / pharmacology*
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship
  • Thiourea / chemistry
  • Thiourea / pharmacology*
  • Urea / chemistry
  • Urea / pharmacology*

Substances

  • Antineoplastic Agents
  • Urea
  • Thiourea
  • Guanidine
  • Colchicine